Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models
A new study of mice and lab-grown human colon "organoids" indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.
Source: news-medical.net